Clinical Trial Update: A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study of methotrexate with and without AZD9056 in rheumatoid arthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• AZD9056
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 1 | Status: WITHDRAWN